Patents by Inventor Dale E. Robinson

Dale E. Robinson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240124444
    Abstract: Provided herein are compounds of Formula (I) and pharmaceutically acceptable salts, tautomers, isotopologues, or stereoisomers thereof, wherein R1, R2, R3, R4 and R5 are as defined herein (referred to herein as “Heterocyclic Compounds”), compositions comprising an effective amount of a Heterocyclic Compound, as well as methods of preventing and/or treating cryptosporidiosis and/or inhibiting a parasite or parasitic activity.
    Type: Application
    Filed: December 27, 2021
    Publication date: April 18, 2024
    Applicant: Celgene Corporation
    Inventors: Dale E. Robinson, Natalie Hawryluk, Stacie Canan
  • Publication number: 20090203132
    Abstract: The present invention provides pyrrolidinyl compounds that are useful for preparing conjugated oligomeric compounds. The conjugated pyrrolidinyl compounds can be attached to support medium and provide a free hydroxyl for oligomer synthesis to prepare an oligmeric compound having a 3?-conjugate. Alternatively, the pyrrolidinyl compound can be prepared as a phosphoramidite which can be placed internally or at the 5?-position of an oligomeric compound. These two strategies can be used together to prepare oligomeric compounds having 2 or more conjugates at any selected positions. The present invention also provides methods for modulating gene expression using the conjugated oligomeric compounds.
    Type: Application
    Filed: September 1, 2005
    Publication date: August 13, 2009
    Inventors: Eric E. Swayze, Dale E. Robinson, JR., Elizabeth Anne Jefferson, Prasad Dande, Thazha P. Prakash, Charles Allerson, Balkrishen Bhat
  • Patent number: 7432264
    Abstract: Provided are antibacterial biaryl compounds having micromolar MIC activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain.
    Type: Grant
    Filed: August 9, 2004
    Date of Patent: October 7, 2008
    Assignee: Isis Pharmaceuticals, Inc.
    Inventors: Elizabeth Anne Jefferson, Eric E. Swayze, Punit P. Seth, Dale E. Robinson, Jr.
  • Patent number: 7344851
    Abstract: Prenylating enzymes are involved in modifying oncoproteins, such as RAS, so that growth of neoplastic cells becomes uncontrolled. Inactivation of such enzymes can prevent uncontrolled growth. ?-Dicarbonyl compounds can be used to covalently modify and thereby inactivate prenylating enzymes such as protein farnesyltransferase and protein geranylgeranyltransferase. The compounds can be designed to enhance affinity and/or specificity for a particular protein substrate.
    Type: Grant
    Filed: October 11, 2005
    Date of Patent: March 18, 2008
    Assignee: Arizona Biomedical Research Commission
    Inventors: Seth D. Rose, Steven R. Ottersberg, Karl J. Okolotowicz, Dale E. Robinson, Rosemarie F. Hartman, Scott Lefler
  • Patent number: 7012097
    Abstract: Prenylating enzymes are involved in modifying oncoproteins, such as RAS, so that growth of neoplastic cells becomes uncontrolled. Inactivation of such enzymes can prevent uncontrolled growth. ?-Dicarbonyl compounds can be used to covalently modify and thereby inactivate prenylating enzymes such as protein farnesyltransferase and protein geranylgeranyltransferase. The compounds can be designed to enhance affinity and/or specificity for a particular protein substrate.
    Type: Grant
    Filed: May 14, 2003
    Date of Patent: March 14, 2006
    Assignee: The Arizona Disease Control Research Commission
    Inventors: Seth D. Rose, Steven R. Ottersberg, Karl J. Okolotowicz, Dale E. Robinson, Rosemarie Hartman, Scott Lefler
  • Publication number: 20030219847
    Abstract: Prenylating enzymes are involved in modifying oncoproteins, such as RAS, so that growth of neoplastic cells becomes uncontrolled. Inactivation of such enzymes can prevent uncontrolled growth. &agr;-Dicarbonyl compounds can be used to covalently modify and thereby inactivate prenylating enzymes such as protein farnesyltransferase and protein geranylgeranyltransferase. The compounds can be designed to enhance affinity and/or specificity for a particular protein substrate.
    Type: Application
    Filed: May 14, 2003
    Publication date: November 27, 2003
    Applicant: The Arizona Disease Control Research Commission
    Inventors: Seth D. Rose, Steven R. Ottersberg, Karl J. Okolotowicz, Dale E. Robinson, Rosemarie Hartman, Scott Lefler
  • Patent number: 6576436
    Abstract: Prenylating enzymes are involved in modifying oncoproteins, such as RAS, so that growth of neoplastic cells becomes uncontrolled. Inactivation of such enzymes can prevent uncontrolled growth. &agr;-Dicarbonyl compounds can be used to covalently modify and thereby inactivate prenylating enzymes such as protein farnesyltransferase and protein geranylgeranyltransferase. The compounds can be designed to enhance affinity and/or specificity for a particular protein substrate.
    Type: Grant
    Filed: December 9, 1999
    Date of Patent: June 10, 2003
    Assignee: The Arizona Disease Control Research Commission
    Inventors: Seth D. Rose, Steven R. Ottersberg, Karl J. Okolotowicz, Dale E. Robinson, Rosemarie Hartman, Scott Lefler
  • Patent number: 5040470
    Abstract: A method and system for flue gas recirculation is disclosed which will minimize NOx production from hydrocarbon combustion. In the present invention a furnace having an oxygen-bearing primary source of combustion air, a mixing chamber, a combustion chamber in downstream communication with the mixing chamber and an exhaust section downstream of the combustion chamber is provided with a flue gas recirculation line. The recirculation line establishes communication between the exhaust section and the mixing chamber for the return of combustion products as a secondary source of combustion air which is relatively lean in oxygen and is combined with the primary source of combustion air in the mixing chamber. The ratio of flow rates for the primary and secondary sources of combustion air is controlled by a signal generated by a sensor which senses the oxygen concentration in the mixing chamber.
    Type: Grant
    Filed: November 15, 1990
    Date of Patent: August 20, 1991
    Assignee: Shell Western E&P Inc.
    Inventors: Ruth E. Lofton, Dale E. Robinson, Daniel H. Hutchinson
  • Patent number: 5002484
    Abstract: A method and system for flue gas recirculation is disclosed which will minimize NOx production from hydrocarbon combustion. In the present invention a furnace having an oxygen-bearing primary source of combustion air, a mixing chamber, a combustion chamber in downstream communication with the mixing chamber and an exhaust section downstream of the combustion chamber is provided with a flue gas recirculation line. The recirculation line establishes communication between the exhaust section and the mixing chamber for the return of combustion products as a secondary source of combustion air which is relatively lean in oxygen and is combined with the primary source of combustion air in the mixing chamber. The ratio of flow rates for the primary and secondary sources of combustion air is controlled by a signal generated by a sensor which senses the oxygen concentration in the mixing chamber.
    Type: Grant
    Filed: March 25, 1988
    Date of Patent: March 26, 1991
    Assignee: Shell Western E&P Inc.
    Inventors: Ruth E. Lofton, Dale E. Robinson, Daniel H. Hutchinson